Research needed to support clinical use of biomarkers as prognostic indicators for patients with heart failure

Cardiology Research and Practice

Volumn 1, Issue 1, 2010, Pages

  Rector, Thomas S ^a,b   Anand, Inder S ^a,b  

^a VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; TROPONIN T;

ADVERSE OUTCOME; CLASSIFICATION; HEART FAILURE; HOSPITAL READMISSION; HUMAN; MORTALITY; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 79959428022     PISSN: None     EISSN: 20900597     Source Type: Journal    
DOI: 10.4061/2010/453851     Document Type: Review

References (24)

1. de Virginy D. R. B., Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure: a clinical review Heart Failure Reviews 2006 11 4 333 334
2. Lee D. S., Vasan R. S., Novel markers for heart failure diagnosis and prognosis Current Opinion in Cardiology 2005 20 3 201 210 (Pubitemid 40704877)
3. Jourdain P., Jondeau G., Funck F., Gueffet P., Le Helloco A., Donal E., Aupetit J. F., Aumont M. C., Galinier M., Eicher J. C., Cohen-Solal A., Juillire Y., Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP ulticenter Study Journal of the American College of Cardiology 2007 49 16 1733 1739 (Pubitemid 46589928)
4. Pfisterer M., Buser P., Rickli H., BNP-guided vs symptom-guided heart failure therapy the trial of intensified vs standard medical therapy in elderly patients with congestive heart failure (TIME-CHF) randomized trial Journal of the American Medical Association 2009 301 4 383 392
5. Jessup M., Abraham W. T., Casey D. E., 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 2009 119 14 1977 2016
6. Cheng V., Kazanagra R., Garcia A., Lenert L., Krishnaswamy P., Gardetto N., Clopton P., Maisel A., A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study Journal of the American College of Cardiology 2001 37 2 386 391
7. Bettencourt P., Azevedo A., Pimenta J., Fries F., Ferreira S., Ferreira A., N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients Circulation 2004 110 15 2168 2174 (Pubitemid 39372496)
8. Levy W. C., Lee K. L., Hellkamp A. S., Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population Circulation 2009 120 10 835 842
9. Hlatky M. A., Greenland P., Arnett D. K., On behalf of the American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council. Criteria for evaluation of novel markers of cardiovascular risk; a scientific statement from the American Heart Association Circulation 2009 119 2408 2416
10. Dunlay S. M., Gerber Y., Weston S. A., Killian J. M., Redfield M. M., Roger V. L., Prognostic value of biomarkers in heart failure: application of novel methods in the community Circulation: Heart Failure 2009 2 5 393 400
11. Lemeshow S., Klar J., Teres D., Outcome prediction for individual intensive care patients: useful, misused, or abused? Intensive Care Medicine 1995 21 9 770 776
12. Henderson R., Keiding N., Individual survival time prediction using statistical models Journal of Medical Ethics 2005 31 12 703 706 (Pubitemid 43013381)
13. Vickers A. J., Kramer B. S., Baker S. G., Selecting patients for randomized trials: a systematic approach based on risk group Trials 2006 7 30 1 8
14. Cohn J. N., Tognoni G., A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure The New England Journal of Medicine 2001 345 23 1667 1675 (Pubitemid 33126822)
15. Anand I. S., Fisher L. D., Chiang Y.-T., Latini R., Masson S., Maggioni A. P., Glazer R. D., Tognoni G., Cohn J. N., Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT) Circulation 2003 107 9 1278 1283 (Pubitemid 36314411)
16. Latini R., Masson S., Anand I. S., Missov E., Carlson M., Vago T., Angelici L., Barlera S., Parrinello G., Maggioni A. P., Tognoni G., Cohn J. N., Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure Circulation 2007 116 11 1242 1249 (Pubitemid 47517535)
17. Pepe M. S., Janes H., Longton G., Leisenring W., Newcomb P., Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker American Journal of Epidemiology 2004 159 9 882 890 (Pubitemid 38657490)
18. Leisenring W., Alonzo T., Pepe M. S., Comparisons of predictive values of binary medical diagnostic tests for paired designs Biometrics 2000 56 2 345 351 (Pubitemid 30422620)
19. Greenland S., The need for reorientation toward cost-effective prediction: comments on Evaluating the added predictive of a new marker: from area under the ROC curve to reclassification and beyond Statistics in Medicine 2008 27 2 199 206 (Pubitemid 351193646)
20. Cook N. R., Ridker P. M., Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures Annals of Internal Medicine 2009 150 11 795 802
21. Janes H., Pepe M. S., Gu W., Assessing the value of risk predictions by using risk stratification tables Annals of Internal Medicine 2008 149 10 751 760
22. Pigeon J. G., Heyse J. F., An improved goodness of fit statistic for probability prediction models Biometrical Journal 1999 41 1 71 82
23. Pencina M. J., D'Agostino R. B. Sr., D'Agostino R. B. Jr., Vasan R. S., Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Statistics in Medicine 2008 27 2 157 172 (Pubitemid 351193639)
24. Melander O., Newton-Cheh C., Almgren P., Novel and conventional biomarkers for prediction of incident cardiovascular events in the community Journal of the American Medical Association 2009 302 1 49 57